Alcamena Stem Cell Therapeutics, LLC
Spencerville, MD
- UEI
- J6DAAQH7AQL8
- CAGE
- 7B1Q9
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 16311 Batson Rd, Spencerville, MD 20868, USA
- Website
- alcamenabio.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Alcamena Stem Cell Therapeutics, LLC is a corporate entity registered in SAM.gov since January 2015, operating as a self-certified small disadvantaged business and for-profit limited liability company located in Spencerville, Maryland. The company specializes in developing innovative therapeutic solutions focusing on neurological conditions, pain management, and drug development, with a particular emphasis on peptidomimetic drugs and biologics. Their strategic approach centers on creating novel drug modalities that target complex medical challenges, particularly in areas of neurological health and pain treatment.
The company has secured multiple significant federal grant awards from key agencies like the Defense Health Agency and the National Institute of Neurological Disorders and Stroke, primarily supporting advanced pharmaceutical research and development. Their grant-funded projects include developing a new drug modality to restore cognitive and psychological health after traumatic brain injury, a novel non-opioid cell and tissue-permeable peptide therapeutic for epigenetic reprogramming of neuropathic pain, and preclinical development of long-acting, non-opioid peptidomimetic drugs for chronic pain management. These grants, ranging from $2.55 million for traumatic brain injury research to ongoing projects in pain management, demonstrate Alcamena's commitment to advancing therapeutic solutions that address critical medical needs, with a specific focus on creating innovative treatments that go beyond symptom management to target underlying physiological mechanisms.
Quick answers
Is Alcamena Stem Cell Therapeutics, LLC registered in SAM.gov?
Yes. Alcamena Stem Cell Therapeutics, LLC's SAM.gov registration is active through August 26, 2027.
What is Alcamena Stem Cell Therapeutics, LLC's CAGE code?
Alcamena Stem Cell Therapeutics, LLC's CAGE code is 7B1Q9, and its Unique Entity ID (UEI) is J6DAAQH7AQL8.
What is Alcamena Stem Cell Therapeutics, LLC's most recent federal award?
Alcamena Stem Cell Therapeutics, LLC's most recent federal grant award is A new drug modality to restore cognitive and psychological health after traumatic brain injury (HT94252510912), from Defense Health Agency, on September 1, 2025.
On GovTribe
See Alcamena Stem Cell Therapeutics, LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors